← brief for 2026-11-02 · Slowing decline

GLP-1 Receptor Agonists and Cardiorenal Outcomes in Non-Obese, Non- Diabetic MASLD: A Propensity Score-Matched Study

Preprint C Not peer reviewed Observational

Key takeaways

This preprint studied people with liver disease who were not obese or diabetic. It looked at whether using GLP-1 drugs affected their heart and kidney health. It is an observational study, so it shows a link but not proof of cause. The results are not yet peer reviewed.

Who did this work

Anh Thu Nguyen (The University of Texas Medical Branch at Galveston) · Yahya Haj Hamad (The University of Texas Medical Branch at Galveston) · Riddhi Prateek (The University of Texas Medical Branch at Galveston) · Daanish Imam (The University of Texas Medical Branch at Galveston) · Harish Gopalakrishna (The University of Texas Medical Branch at Galveston) · Gurinder K. Luthra (The University of Texas Medical Branch at Galveston)

Source

Preprint · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-01
https://doi.org/10.21203/rs.3.rs-11195753/v1